Literature DB >> 20693896

Chronic pancreatitis.

Matthew J DiMagno1, Eugene P DiMagno.   

Abstract

PURPOSE OF REVIEW: We review important new clinical observations in chronic pancreatitis made in the past year. RECENT
FINDINGS: Cigarette smoking is a dose-dependent risk factor for acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis. A minority of chronic alcohol consumers develop recurrent acute pancreatitis but very heavy drinking associates with chronic pancreatitis. More patients with alcohol-induced chronic pancreatitis have cirrhosis than patients with cirrhosis have chronic pancreatitis (39 vs. 18%). Most patients with asymptomatic hyperenzymemia have no pancreatic lesions. Pancreatic calcifications are most frequently due to chronic pancreatitis, followed by cystic neoplasms and other disorders. The new Rosemont consensus classification of endoscopic ultrasonography criteria for chronic pancreatitis is unvalidated. Zinc deficiency correlates only with severe chronic pancreatitis and the fecal elastase test is an inaccurate marker of pancreatic steatorrhea. Patients commonly receive insufficient lipase to abolish pancreatic steatorrhea. Ultrastructural neuropathies are common to chronic pancreatitis and pancreatic cancer and correlate with pain severity.
SUMMARY: Results of this year's investigations further elucidated risk factors for pancreatic disease, the natural history of alcoholic pancreatitis, the differential diagnosis of pancreatic calcifications, the diagnosis of chronic pancreatitis with the Rosemont criteria, the limited diagnostic utility of fecal elastate test and zinc measurements, the proper dosing of pancreatic enzyme supplements, and treatment of pancreatic pain.

Entities:  

Mesh:

Year:  2010        PMID: 20693896     DOI: 10.1097/MOG.0b013e32833d11b2

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  6 in total

1.  Definitions of pediatric pancreatitis and survey of present clinical practices.

Authors:  Veronique D Morinville; Sohail Z Husain; Harrison Bai; Bradley Barth; Rabea Alhosh; Peter R Durie; Steven D Freedman; Ryan Himes; Mark E Lowe; John Pohl; Steven Werlin; Michael Wilschanski; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

Review 2.  Chronic pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2011-09       Impact factor: 3.287

3.  Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group.

Authors:  Ákos Szücs; Tamás Marjai; Andrea Szentesi; Nelli Farkas; Andrea Párniczky; György Nagy; Balázs Kui; Tamás Takács; László Czakó; Zoltán Szepes; Balázs Csaba Németh; Áron Vincze; Gabriella Pár; Imre Szabó; Patrícia Sarlós; Anita Illés; Szilárd Gódi; Ferenc Izbéki; Judit Gervain; Adrienn Halász; Gyula Farkas; László Leindler; Dezső Kelemen; Róbert Papp; Richárd Szmola; Márta Varga; József Hamvas; János Novák; Barnabás Bod; Miklós Sahin-Tóth; Péter Hegyi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

4.  Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-KrasG12D ) mice.

Authors:  Wei Yu; Yiming Ma; Sanjit K Roy; Rashmi Srivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2021-12-03       Impact factor: 5.310

5.  Model-based iterative reconstruction and adaptive statistical iterative reconstruction: dose-reduced CT for detecting pancreatic calcification.

Authors:  Koichiro Yasaka; Masaki Katsura; Masaaki Akahane; Jiro Sato; Izuru Matsuda; Kuni Ohtomo
Journal:  Acta Radiol Open       Date:  2016-01-22

6.  Chronic ethanol exposure of human pancreatic normal ductal epithelial cells induces cancer stem cell phenotype through SATB2.

Authors:  Wei Yu; Yiming Ma; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2018-05-15       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.